C
Cameron G. McDougall
Researcher at Johns Hopkins University School of Medicine
Publications - 282
Citations - 17269
Cameron G. McDougall is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Aneurysm & Embolization. The author has an hindex of 62, co-authored 278 publications receiving 15177 citations. Previous affiliations of Cameron G. McDougall include Barrow Neurological Institute & Cameron International.
Papers
More filters
Journal ArticleDOI
O-010 The Barrow Neurological Institute Experience with the Pipeline Embolisation Device: Results in the First 100 Patients Treated after FDA Approval
TL;DR: The PED is a safe and effective means of treating complex cerebral aneurysms Nonetheless, a number of technical factors and patient compliance issues complicate its use.
Journal ArticleDOI
Clipping of a Mycotic Basilar Trunk Aneurysm under Cardiac Arrest in a Pregnant AIDS Patient.
TL;DR: The first case of a coccidioidomycosis mycotic anterior inferior cerebellar artery (AICA) aneurysm that was clipped under hypothermic cardiac standstill in a pregnant acquired immunodeficiency syndrome (AIDS) patient is presented.
Journal ArticleDOI
Endovascular treatment of basilar artery aneurysms
Jonathan J. Baskin,A. Giancarlo Vishteh,Nicholas Theodore,Cameron G. McDougall,Robert F. Spetzler +4 more
TL;DR: Four patient series included in this critique were composed of similar numbers of patients who had aneurysms that predominantly involved the basilar artery bifurcation and who presented clinically after a subarachnoid hemorrhage, and studies support the following conclusions regarding GDC-mediated electrothrombosis for the treatment of aneurYSms.
Journal ArticleDOI
Outcome of Oculomotor Nerve Palsy from Posterior Communicating Artery Aneurysms
P. Roc Chen,Sepi Amin-Hanjani,Felipe C. Albuquerque,Cameron G. McDougall,Joseph M. Zabramski,Robert F. Spetzler +5 more
Journal Article
Abstract 208: Detailed Analysis of the 30-day Outcomes in the Stenting Arm of the SAMMPRIS Trial
Colin P. Derdeyn,David Fiorella,Michael J. Lynn,Elad I. Levy,Brian L. Hoh,Stanley L. Barnwell,Lee Pride,O. O. Zaidat,Harry J. Cloft,Cameron G. McDougall,Richard P. Klucznik,Bethany F Lane,Tanya N Turan,Scott Janis,Marc I Chimowitz +14 more
TL;DR: The 30-day events in the SAMMPRIS trial were multi-factorial, with no single factor accounting for the majority of events and will need to address several different mechanisms for this procedure to be proven effective.